Patents by Inventor John Hiscott

John Hiscott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5?-triphosphate oligoribonucleotides
    Patent number: 11028397
    Abstract: Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: June 8, 2021
    Assignee: Oregon Health & Science University
    Inventor: John Hiscott
  • 5'-TRIPHOSPHATE OLIGORIBONUCLEOTIDES
    Publication number: 20190292545
    Abstract: Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
    Type: Application
    Filed: December 12, 2018
    Publication date: September 26, 2019
    Applicant: Oregon Health & Science University
    Inventor: John Hiscott
  • 5?-triphosphate oligoribonucleotides
    Patent number: 10167476
    Abstract: Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: January 1, 2019
    Assignee: Oregon Health & Science University
    Inventor: John Hiscott
  • 5?-triphosphate oligoribonucleotides
    Patent number: 9790509
    Abstract: Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: October 17, 2017
    Assignee: Oregon Health & Science University
    Inventor: John Hiscott
  • 5'-TRIPHOSPHATE OLIGORIBONUCLEOTIDES
    Publication number: 20170268007
    Abstract: Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
    Type: Application
    Filed: May 25, 2017
    Publication date: September 21, 2017
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventor: John Hiscott
  • 5'-TRIPHOSPHATE OLIGORIBONUCLEOTIDES
    Publication number: 20160017334
    Abstract: Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
    Type: Application
    Filed: July 17, 2015
    Publication date: January 21, 2016
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventor: John Hiscott
  • 5'-TRIPHOSPHATE OLIGORIBONUCLEOTIDES
    Publication number: 20140287023
    Abstract: 5?-triposphate oligoribonucleotides, pharmaceutical compositions comprising said 5?-triposphate oligoribonucleotides, and methods of using said 5?-triposphate oligoribonucleotides to treat viral infections are disclosed.
    Type: Application
    Filed: February 11, 2014
    Publication date: September 25, 2014
    Inventors: John Hiscott, Rongtuan Lin, Meztli Arguello
  • AMPLIFICATION OF CANCER-SPECIFIC ONCOLYTIC VIRAL INFECTION BY HISTONE DEACETYLASE INHIBITORS
    Publication number: 20110044952
    Abstract: The invention provides methods for treating cancer cells in a host by infecting the cancer cells with one or more strains of oncolytic virus, in conjunction with treating the host with an amount of an HDI that is effective to augment the cancer-cell-specific oncolytic infection.
    Type: Application
    Filed: November 26, 2008
    Publication date: February 24, 2011
    Applicant: Ottawa Health Research Institute
    Inventors: John Cameron Bell, John Hiscott, Hesham Abdelbary, Thi Lien-Anh Nguyen, Jean-Simon Diallo